# Arq, Inc. (ARQ) Informational only - not investment advice. CIK: 0001515156 SIC: 2890 Miscellaneous Chemical Products SIC breadcrumb: [Manufacturing](/division/D/) > [Chemicals And Allied Products](/major-group/28/) > [SIC 2890 Miscellaneous Chemical Products](/industry/2890/) Latest 10-K filed: 2026-03-10 SEC page: https://www.sec.gov/edgar/browse/?CIK=1515156 Filing source: https://www.sec.gov/Archives/edgar/data/1515156/000151515626000021/arq-20251231.htm ## At a glance FY2025 · period end 2025-12-31 · filed 2026-03-10 · accession 0001515156-26-000021 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001515156.json | Metric | Value | FY | Provenance | | --- | ---: | ---: | --- | | Revenue | 120,336,000 USD | 2025 | verified | | Net income | -52,610,000 USD | 2025 | verified | | Assets | 230,580,000 USD | 2025 | verified | | Free cash flow | -11,306,000 USD | 2025 | computed | | Net margin | -43.72% | 2025 | computed | | Operating margin | -44.01% | 2025 | computed | | Revenue YoY | +10.44% | 2025 | computed | | ROE | -31.32% | 2025 | computed | Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Free cash flow = operating cash flow − capital expenditures. Net margin = net income ÷ revenue. Operating margin = operating income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity. No market price, no rating, no forecast on this site. Not investment advice. ### Peer percentile fingerprint | Ratio | ARQ | Peer median | Percentile | N | | --- | ---: | ---: | ---: | ---: | | Net margin | -43.7% | 1.2% | 18 | 219 | | Operating margin | -44.0% | 3.0% | 22 | 201 | | Revenue growth | 10.4% | 8.0% | 55 | 251 | | FCF margin | -9.4% | -1.7% | 43 | 251 | | ROE | -31.3% | -23.2% | 42 | 314 | | ROA | -22.8% | -12.1% | 42 | 340 | | Liabilities / equity | 0.37 | 0.61 | 40 | 319 | | Current ratio | 1.04 | 3.93 | 4 | 341 | Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC major-group 28 Chemicals And Allied Products, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking. ## Selected Fundamentals | Metric | Value | Unit | FY | Filed | | --- | ---: | --- | ---: | --- | | Revenue | 120336000 | USD | 2025 | 2026-03-10 | | Net income | -52610000 | USD | 2025 | 2026-03-10 | | Assets | 230580000 | USD | 2025 | 2026-03-10 | ## Financials Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-03-10. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001515156.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts. | Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | | | | | 45,364,000 | | 70,086,000 | 67,363,000 | 100,294,000 | 102,987,000 | 99,183,000 | 108,959,000 | 120,336,000 | | Net income | | | | 97,678,000 | 27,873,000 | 35,454,000 | 35,537,000 | -20,302,000 | 60,401,000 | -8,917,000 | -12,249,000 | -5,109,000 | -52,610,000 | | Operating income | | | | -16,098,000 | -4,142,000 | -6,400,000 | -14,893,000 | -40,981,000 | 4,852,000 | -12,068,000 | -13,335,000 | -1,959,000 | -52,958,000 | | Diluted EPS | | | | 4.34 | 1.29 | 1.76 | 1.93 | -1.12 | 3.27 | -0.48 | -0.42 | -0.14 | -1.27 | | Operating cash flow | | | | -18,257,000 | -11,748,000 | -9,889,000 | 62,262,000 | 54,048,000 | 25,999,000 | -6,061,000 | -16,653,000 | 10,477,000 | -2,730,000 | | Capital expenditures | | | | | 428,000 | 467,000 | 7,851,000 | 6,685,000 | 6,201,000 | 8,914,000 | 27,516,000 | 85,170,000 | 8,576,000 | | Assets | | | | 107,296,000 | 82,618,000 | 159,664,000 | 173,799,000 | 146,671,000 | 185,436,000 | 181,164,000 | 235,502,000 | 284,368,000 | 230,580,000 | | Liabilities | | | | 31,131,000 | 9,163,000 | 91,717,000 | 65,507,000 | 61,461,000 | 38,135,000 | 41,185,000 | 57,102,000 | 67,092,000 | 62,617,000 | | Stockholders' equity | | | | 76,165,000 | 73,455,000 | 67,947,000 | 108,292,000 | 85,210,000 | 147,301,000 | 139,979,000 | 178,400,000 | 217,276,000 | 167,963,000 | | Cash and cash equivalents | 37,890,000 | 25,181,000 | 9,265,000 | 13,208,000 | 30,693,000 | | | | 78,753,000 | 66,432,000 | 45,361,000 | 13,516,000 | 6,573,000 | | Free cash flow | | | | | -12,176,000 | -10,356,000 | 54,411,000 | 47,363,000 | 19,798,000 | -14,975,000 | -44,169,000 | -74,693,000 | -11,306,000 | ### Ratios ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported. | Metric | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Net margin | | | | | 61.44% | | 50.70% | -30.14% | 60.22% | -8.66% | -12.35% | -4.69% | -43.72% | | Operating margin | | | | | -9.13% | | -21.25% | -60.84% | 4.84% | -11.72% | -13.44% | -1.80% | -44.01% | | Return on equity | | | | 128.25% | 37.95% | 52.18% | 32.82% | -23.83% | 41.01% | -6.37% | -6.87% | -2.35% | -31.32% | | Return on assets | | | | 91.04% | 33.74% | 22.21% | 20.45% | -13.84% | 32.57% | -4.92% | -5.20% | -1.80% | -22.82% | | Liabilities / equity | | | | 0.41 | 0.12 | 1.35 | 0.60 | 0.72 | 0.26 | 0.29 | 0.32 | 0.31 | 0.37 | | Current ratio | | | | 1.64 | 5.36 | 1.47 | 1.20 | 1.46 | 4.79 | 4.42 | 3.75 | 1.17 | 1.04 | ## As-reported value updates 2 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period. Ledger: /company/ARQ/revisions/ ## Quarterly Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-08-10. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001515156.json. Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived. | Quarter | End date | Revenue | Net income | Diluted EPS | Method | | --- | --- | ---: | ---: | ---: | --- | | 2022-Q3 | 2022-09-30 | | | -0.13 | reported discrete quarter | | 2023-Q1 | 2023-03-31 | | | -0.32 | reported discrete quarter | | 2023-Q2 | 2023-06-30 | | | -0.21 | reported discrete quarter | | 2023-Q3 | 2023-06-30 | | -5,856,000 | | reported discrete quarter | | 2023-Q3 | 2023-09-30 | 29,829,000 | | -0.07 | reported discrete quarter | | 2023-Q4 | 2023-12-31 | 28,104,000 | 3,290,000 | | derived Q4 = FY annual - nine-month YTD | | 2024-Q1 | 2024-03-31 | 21,740,000 | -3,419,000 | -0.09 | reported discrete quarter | | 2024-Q2 | 2024-03-31 | | -3,419,000 | | reported discrete quarter | | 2024-Q2 | 2024-06-30 | 25,405,000 | | -0.06 | reported discrete quarter | | 2024-Q3 | 2024-06-30 | | -1,968,000 | | reported discrete quarter | | 2024-Q3 | 2024-09-30 | 34,774,000 | | 0.04 | reported discrete quarter | | 2024-Q4 | 2024-12-31 | 27,040,000 | -1,339,000 | | derived Q4 = FY annual - nine-month YTD | | 2025-Q1 | 2025-03-31 | 27,247,000 | 203,000 | 0.00 | reported discrete quarter | | 2025-Q2 | 2025-03-31 | | 203,000 | | reported discrete quarter | | 2025-Q2 | 2025-06-30 | 28,584,000 | | -0.05 | reported discrete quarter | | 2025-Q3 | 2025-06-30 | | -2,133,000 | | reported discrete quarter | | 2025-Q3 | 2025-09-30 | 35,074,000 | | -0.02 | reported discrete quarter | | 2025-Q4 | 2025-12-31 | 29,431,000 | -50,027,000 | | derived Q4 = FY annual - nine-month YTD | | 2026-Q1 | 2026-03-31 | 29,053,000 | -842,000 | -0.02 | reported discrete quarter | | 2026-Q2 | 2026-03-31 | | -1,137,000 | | reported discrete quarter | | 2026-Q2 | 2026-06-30 | 29,883,000 | | -0.02 | reported discrete quarter | ## Filed narrative (10-K & 10-Q) ## Business Verbatim Item 1 Business section from ARQ's latest 10-K: [/company/ARQ/business/](/company/ARQ/business/). ## Risk Factors Verbatim Item 1A Risk Factors from ARQ's latest 10-K: [/company/ARQ/risk-factors/](/company/ARQ/risk-factors/). ## Latest quarter (10-Q) Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1515156/000151515626000114/arq-20260630.htm Extracted from a substantive MD&A body after the formal Item 2 span was a TOC or reference stub. Confidence: high Filing date: 2026-08-10 Report date: 2026-06-30 Overview We are an environmental technology company that is principally engaged in the sale of consumable air, water and soil treatment solutions primarily based on activated carbon ("AC"). Our proprietary AC products enable customers to reduce air, water, and soil contaminants, including mercury, per- and polyfluoroalkyl substances ("PFAS") and other pollutants, to meet the challenges of existing and pending air quality and water regulations. We manufacture and sell AC and other chemicals used to capture and remove impurities, contaminants, and pollutants for the coal-fired power generation, industrial, water treatment, and water and soil remediation markets, which we collectively refer to as the advanced purification technologies ("APT") market. Our primary products are comprised of AC, which is produced from a variety of carbonaceous raw materials. Our AC products include both powdered activated carbon ("PAC") and granular activated carbon ("GAC"). Additionally, we own the Five Forks Mine, a lignite mine located in Saline, Louisiana, that currently supplies the primary raw material for the manufacturing of our products. We also control bituminous coal waste reserves and own a manufacturing facility, both located in Corbin, Kentucky (the "Corbin Facility"), and a process to recover and purify the bituminous coal fines. Using the Corbin Facility's manufacturing process, we convert coal waste into a purified, microfine carbon powder ("Corbin Wetcake") for use in high-value applications. On August 6, 2025, we announced that we had successfully commissioned our Red River Plant’s GAC Facility (the "GAC Facility") and produced our first commercial volumes of on-specification GAC product. However, after initial production runs, in December 2025, it became clear that ramp-up to nameplate capacity could not be accomplished without further modifications to the existing systems because of design flaws in our GAC Facility. In March 2026, we decided to pause GAC production, continue to idle the Corbin Facility as a cost saving measure, and launch an engineering and production process optimization review, including an evaluation of potential GAC Facility design modifications and production economics at different scales. Additionally, we now expect to transition away from using Corbin Wetcake for the production of our GAC products to a bituminous coal feedstock with proven performance. We continue to believe that Corbin Wetcake has the potential to enable us to access new markets and applications. We intend to secure customer interest in Corbin Wetcake as an additive into other markets, such as a component for asphalt, or for use in the purified coal and synthetic graphite industries. In addition, we are exploring uses for certain rare earth minerals and critical elements that can be contained within material from the manufacturing process at our Corbin Facility for further recovery and concentration by others. These applications are currently in early stages of proof-of-concept testing or preliminary customer testing. Drivers of Demand and Key Factors Affecting Profitability Drivers of demand and current key factors affecting our profitability are sales of our AC products to the APT market. Our operating results are influenced by: (1) changes in our manufacturing production and sales volumes; (2) changes in price and product mix; (3) changes in coal-fired dispatch and electricity power generation sources; (4) changes in demand for contaminant removal within water treatment facilities; (5) changes in environmental regulations; and (6) state or municipal approval and customer acceptance of our new products. For the three and six months ended June 30, 2026, we experienced an increase in demand for our products from certain coal-fired dispatch and electricity power generation customers compared to the same period in 2025. This was primarily due to the year-to-date impact of moderate to severe temperatures during the winter and summer seasons, resulting in higher demand for power generation, and the impact of steady natural gas prices, resulting in several large utility customers opting to use coal versus natural gas as a primary source for power generation. Additionally, demand for power generation has grown and continues to grow driven by macroeconomic trends, such as increased consumption related to data and computer centers, electric vehicles, and other large-scale power consumers. We expect that natural gas prices will remain relatively consistent through 2026 at an elevated level due to increased demand for liquid natural gas exports, and conflict in the Middle East impacting supply, partially offset by increases in anticipated natural gas inventory levels. 20 GAC Engineering and Production Process Optimization Review The decision to pause GAC production, continue idling the Corbin Facility as a cost saving measure, and launch an engineering and production process optimization review was made in March 2026, following the review of independent testing results received in January 2026. This testing demonstrated that the thermal oxidizer in place could only support approximately 15 million pounds of annual GAC production, and would require additional modifications to achieve our original design capacity of 25 million pounds or higher. Our analysis indicates that a 15 million pound per year scenario on a stand-alone basis does not provide sufficient returns to make it economically attractive. The optimization review remains ongoing and is expected to determine production scale, capital requirements, and return profiles before we commit to additional investment in our GAC Facility. We have since expanded the optimization review to include a broader operational assessment of our overall business, which has focused on maximizing furnace throughput and reducing unit costs for each of our products, including our PAC and GAC products. These additional constraints emerged as we prepared to transition from our Corbin Wetcake to bituminous coal with proven performance, a solution which is expected to address previously announced design flaws and constraints at our GAC Facility. The issues that we experienced with our thermal oxidizer and their impact on the capacity of our GAC Facility stemmed from the previously disclosed design flaws by the engineering firm originally engaged to design our GAC Facility, with whom litigation remains ongoing. Due to the issues described above, we do not expect GAC production in fiscal year 2026 or 2027. Results of Operations For the three and six months ended June 30, 2026, we recognized net loss of $0.7 million and $1.9 million, respectively, compared to net loss of $2.4 million and $2.4 million, respectively, for the three and six months ended June 30, 2025. The most significant factors impacting results between periods for the three months ended June 30, 2026 and June 30, 2025 were increases in revenue due to increased pricing and demand for our products, offset by increases in severance expense related to the previously disclosed departures of certain members of our executive team. The following sections provide additional information regarding these comparable periods. For comparability purposes, the following tables set forth our results of operations for the periods presented in the Condensed Consolidated Financial Statements included in Item 1 of this Quarterly Report. The current year period to prior year period comparisons of financial results may not be indicative of financial results to be achieved in future periods. Comparison of the Three Months Ended June 30, 2026 and 2025 Revenue and Cost of revenue A summary of the components of Revenue and Cost of revenue, exclusive of depreciation and amortization for the three months ended June 30, 2026 and 2025 is as follows: [[GREPCENT_TABLE]] [["","","Three Months Ended June 30,","","Change"],["(in thousands, except percentages)","","2026","","2025","","($)","","(%)"],["Revenue","","$","29,883","","","$","28,584","","","$","1,299","","","5","%"],["Cost of revenue, exclusive of depreciation and amortization","","$","18,372","","","$","19,066","","","$","(694)","","","(4)","%"]] [[/GREPCENT_TABLE]] Revenue and Cost of revenue For the three months ended June 30, 2026, revenue increased from the comparable quarter in 2025 primarily driven by the impact of increased pricing, which contributed additional revenues of $1.3 million, as well as higher sales volumes of our AC products, which contributed additional revenues of approximately $1.0 million of the total revenue increase. These increases were partially offset by a decrease in revenue attributable to lower sales of our chemicals products during the three months ended June 30, 2026, which caused revenue to decrease by $1.1 million from the comparable quarter in 2025. The increases due to higher pricing and volumes sold were primarily attributable to sales to customers in the power-generation market, driven by seasonal electricity demand. Notably, our revenues continue to be impacted by electricity demand driven by seasonal weather and power generation needs. 21 During the three months ended June 30, 2026, our gross margin was favorably impacted by both the pause in production at our Corbin Facility, which we idled indefinitely as of December 2025, and improved mix during the three months ended June 30, 2026 due to lower sales of our lower-margin chemical products compared to the same period in 2025. These favorable impacts to gross margin were partially offset by an increase in our costs per unit during the three months ended June 30, 2026, which were primarily due to increases in salaries and wages of our operations personnel and utilities costs. These factors resulted in the majority of the approximately $0.7 million decrease in Cost of revenue, exclusive of depreciation and amortization for the three months ended June 30, 2026 compared to the comparable quarter in 2025. We expect that revenue will continue to be positively impacted by demand for our PAC products. As we have paused production of our GAC products at our Red River Plant, we expect that gross margin will continue to improve as the impact of fixed production costs related to our GAC products on our gross margin lessens. Further, as we conduct a comprehensive engineering and production process optimization review related to our GAC products, we expect to improve the operational efficiency of PAC production at our Red River Plant and improve our product mix to higher margin products. Operating Expenses A summary of the components of our operating expenses for the three months ended June 30, 2026 and 2025 is as follows: [[GREPCENT_TABLE]] [["","","Three Months Ended June 30,","","Change"],["(in thousands, except percentages)","","2026","","2025As Adjusted (1)","","($)","","(%)"],["Operating expenses:"],["Selling, general and administrative","","$","6,789","","","$","5,918","","","$","871","","","15","%"],["Research and development","","958","","","2,697","","","(1,739)","","","(64)","%"],["Depreciation, amortization, depletion and accretion","","3,542","","","2,721","","","821","","","30","%"],["Loss (gain) on sale of assets","","290","","","(27)","","","317","","","*"],["","","$","11,579","","","$","11,309","","","$","270","","","2","%"]] [[/GREPCENT_TABLE]] (1) Adjusted to reflect the retrospective change in accounting method for planned major maintenance costs. See Note 1 and Note 12 of Notes to Condensed Consolidated Financial Statements included in this Quarterly Report for further discussion. * Percent change in excess of 100% not considered meaningful. Selling, General and Administrative A summary of the components of selling, general and administrative expenses for the three months ended June 30, 2026 and 2025 is as follows: [Excerpt truncated for page length; source filing is linked above.] ## Latest 10-K MD&A (excerpt) Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1515156/000151515626000021/arq-20251231.htm Complete FY 2025 MD&A: /company/ARQ/mda/fy2025/ Extracted structurally from real Item 7 body heading to real Item 7A/8 boundary. Confidence: high Filing date: 2026-03-10 Report date: 2025-12-31 Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations The following discussion and analysis of our financial condition and results of our operations should be read together with the audited Condensed Consolidated Financial Statements and notes of Arq, Inc. included in Item 1 of Part II, Item 8 of this Form 10-K. The results of operations discussed in this "Management's Discussion and Analysis of Financial Condition and Results of Operations" are those of Arq, Inc. and its consolidated subsidiaries, collectively, the "Company," "we," "our" or "us." Overview We are an environmental technology company that is principally engaged in the sale of consumable air, water and soil treatment solutions primarily based on activated carbon ("AC"). Our proprietary AC products enable customers to reduce air, water, and soil contaminants, including mercury, per- and polyfluoroalkyl substances ("PFAS") and other pollutants, to meet the challenges of existing and pending air quality and water regulations. We manufacture and sell AC and other chemicals used to capture and remove impurities, contaminants, and pollutants for the coal-fired power generation, industrial, water treatment, and water and soil remediation markets, which we collectively refer to as the advanced purification technologies ("APT") market. Our primary products are comprised of AC, which is produced from a variety of carbonaceous raw materials. Our AC products include both powdered activated carbon ("PAC") and granular activated carbon ("GAC"). Additionally, we own a lignite mine located in Saline, Louisiana (the "Five Forks Mine") that currently supplies the primary raw material for the manufacturing of the majority of our products. We also control bituminous coal waste reserves and own a manufacturing facility, both located in Corbin, Kentucky (the "Corbin Facility"), and a process to recover and purify the bituminous coal fines. Using the Corbin Facility's manufacturing process, we convert coal waste into a purified, microfine carbon powder for high value applications ("Corbin Wetcake"). On August 6, 2025, we announced that we had successfully commissioned our Red River Plant’s GAC Facility (the "GAC Facility") and produced our first commercial volumes of on-specification GAC product. However, after initial production runs, in December 2025, it became clear that ramp-up to nameplate capacity could not be accomplished without further modifications to the existing systems because of design flaws in our GAC Facility, on a standalone basis as well as in combination with the inherent variability of Corbin Wetcake, which we planned to use to manufacture our GAC products. As a result, we have paused GAC production, idled the Corbin Facility as a cost saving measure, and have launched an engineering and production process optimization review, which will include an evaluation of potential GAC Facility design modifications and production economics at different scales. Additionally, we now expect to transition away from using Corbin Wetcake for the production of our GAC products to a bituminous proven performance coal feedstock, which we believe can more effectively overcome design constraints. See "Item 7. Management's Discussion and Analysis of Financial Condition and Results of Operations – Drivers of Demand and Key Factors Affecting Profitability" for further information. As a result of the adverse impacts noted above related to the Corbin Facility and GAC production and as part of our periodic review of the carrying values of our long-lived assets, we performed an impairment analysis of the Corbin Facility long-lived assets (the "Corbin Asset Group") as of December 31, 2025. We determined that the estimated undiscounted cash flows for the Corbin Asset Group were less than its carrying value, and the Corbin Asset Group was impaired. The Company further determined that the GAC Facility assets were not impaired as the estimated undiscounted cash flows associated with the assets exceeded their carrying value. Accordingly, we completed a valuation of the Corbin Asset Group with the assistance of an independent third party to estimate its fair value. We estimated the fair value of the Corbin Asset Group at $10.9 million and recorded an impairment charge (the "Corbin Impairment Charge") and corresponding write-down of the Corbin Asset Group in the amount of $38.1 million. Included in this amount is also $0.3 million of Corbin Wetcake inventory that was written-off as of December 31, 2025. In addition, the Company concluded that the intangible asset, developed technology, which comprised a number of patents and other intellectual property attributable to the proprietary manufacturing process for Corbin Wetcake, was also impaired and that its estimated fair value as of December 31, 2025 was zero. Accordingly, the Company recorded an impairment charge and a corresponding write-down of the developed technology in the amount of $6.6 million as of December 31, 2025. We believe that Corbin Wetcake has the potential to enable us to access new markets and applications. We intend to secure customer interest in Corbin Wetcake as an additive into other markets, such as a component for asphalt, or for use in the purified coal and synthetic graphite industries. In addition, we are exploring uses for certain rare earth minerals and critical elements that can be isolated during the manufacturing process at our Corbin Facility for use in a variety of applications. These applications are currently in various stages of proof of concept testing or preliminary customer testing. 27 Drivers of Demand and Key Factors Affecting Profitability Drivers of demand and current key factors affecting our profitability are sales of our AC products to the APT market. Our operating results are influenced by: (1) changes in our manufacturing production and sales volumes; (2) changes in price and product mix; (3) changes in coal-fired dispatch and electricity power generation sources; (4) changes in demand for contaminant removal within water treatment facilities; (5) changes in environmental regulations; and (6) state or municipal approval and customer acceptance of our new GAC products once production recommences. GAC Engineering and Production Process Optimization Review As previously disclosed, on August 6, 2025, we announced that we had successfully commissioned our GAC Facility and produced our first commercial volumes of on-specification GAC product. However, after initial production runs, in December 2025, it became clear that ramp-up to nameplate capacity could not be accomplished without further modifications to the existing systems because of design flaws in our GAC Facility. As a result, we have paused GAC production, idled the Corbin Facility as a cost saving measure, and have launched an engineering and production process optimization review, which will include an evaluation of potential GAC Facility design modifications and production economics at different scales. This decision follows independent testing results received in January 2026 demonstrating that our current thermal oxidizer can only support approximately 15 million pounds of annual GAC production, but will require additional modifications to achieve our original design capacity of 25 million pounds or higher. Our analysis indicates that a 15 million pound per year scenario on a stand-alone basis does not provide sufficient returns to make it economically attractive. The optimization review is expected to determine production scale, capital requirements, and return profiles before we commit to additional investment in our GAC Facility. These constraints emerged as we prepared to transition from our Corbin Wetcake to bituminous proven performance coal, a solution which is expected to address previously announced design and feedstock variability challenges at our GAC Facility. The current issues that we are experiencing with our thermal oxidizer and their impact on the capacity of our GAC Facility stem from the previously disclosed design flaws by the firm originally engaged to design our GAC Facility, with whom litigation remains ongoing. Due to the issues described above, we do not expect material GAC revenue in fiscal year 2026. Components of Revenue, Expenses and Equity Method Investees The following narrative briefly describes the components of revenue and expenses as presented in the Consolidated Statements of Operations. Descriptions of the revenue recognition policies are included in Note 1 to the Consolidated Financial Statements included in Item 8 of this Report. Revenue and cost of revenue Revenue Our revenue is comprised of the sale of AC products and other chemical-based technology products into the APT market, as well as the sale of other AC products to our largest customer, who services other diverse markets. Cost of revenue Cost of revenue is comprised of all labor, fringe benefits, subcontract labor, additive and coal costs, materials, equipment, supplies, travel costs and any other costs and expenses directly related to the cost of production of consumables. License Royalties Payable to Tinuum Group In December 2022, the Company and Tinuum Group entered into an agreement (the "Tinuum Group Royalty Agreement") whereby we pay Tinuum Group a royalty (the "Tinuum Group Royalty") for certain of our sales of M-ProveTM products after the expiration of the tax credit program under IRC Section 45 ("Section 45 Tax Credit Program") (beginning January 1, 2022) to certain refined coal production facilities owned and operated by Tinuum Group (the "Refined Coal Facilities"). The Tinuum Group Royalty is calculated based on "Net Profit" (as defined in the Tinuum Royalty Agreement) on our sales of M-ProveTM product to certain of the Refined Coal Facilities. The Tinuum Group Royalty Agreement is for an initial term of five years with automatic renewals of five years unless we and Tinuum Group agree to terminate it. The Tinuum Group Royalty is included in Consumables cost of revenue. The Tinuum Group Royalty Agreement expires at the end of 2027, with an option to extend. 28 Other Operating Expenses Selling, general and administrative Selling, general and administrative costs include payroll and benefits costs, legal and professional fees, and general and administrative expenses. Payroll and benefits costs include payroll costs, payroll-related fringe benefits and stock-based compensation expense of sales and administrative personnel, but exclude such costs related to direct labor that are included in Cost of revenue. Payroll costs, payroll-related fringe benefits, and stock-based compensation expense of research and development personnel are reported in the Research and development line item in the Consolidated Statements of Operations. Legal and professional costs include external legal, audit and consulting expenses. General and administrative costs include director fees and expenses, bad debt expense, rent and occupancy expense and other general costs of conducting business. Research and development Research and development costs include payroll expenses related to research and development personnel and other expenses incurred related to research and development activities. Research and development costs provided by third parties, net of reimbursements from cost-sharing arrangements, are charged to expense in the period incurred. Depreciation, amortization, depletion and accretion Depreciation and amortization expense consists of depreciation expense related to property, plant and equipment and the amortization of long-lived intangible assets. Depletion and accretion expense consists of depletion expense related to the depletion of mine development costs and the accretion of mine reclamation liabilities. Other (Expense) Income, net Earnings from equity method investment Earnings from equity method investment represe [Excerpt truncated for page length; the complete text is on the linked full-MD&A page.] Read the full FY 2025 MD&A: /company/ARQ/mda/fy2025/ All MD&A years: /company/ARQ/mda/ ## MD&A history Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page. - [FY 2024 MD&A](/company/ARQ/mda/fy2024/): filed 2025-03-05; accession 0001515156-25-000014 (https://www.sec.gov/Archives/edgar/data/1515156/000151515625000014/arq-20241231.htm) - [FY 2023 MD&A](/company/ARQ/mda/fy2023/): filed 2024-03-12; accession 0001515156-24-000036 (https://www.sec.gov/Archives/edgar/data/1515156/000151515624000036/arq-20231231.htm) - [FY 2022 MD&A](/company/ARQ/mda/fy2022/): filed 2023-03-08; accession 0001515156-23-000024 (https://www.sec.gov/Archives/edgar/data/1515156/000151515623000024/ades-20221231.htm) - [FY 2021 MD&A](/company/ARQ/mda/fy2021/): filed 2022-03-08; accession 0001515156-22-000005 (https://www.sec.gov/Archives/edgar/data/1515156/000151515622000005/ades-20211231.htm) ## Macro cross-references Indicators mapped to this company's SIC classification (industry 2890 Miscellaneous Chemical Products) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim. - [INDPRO](/indicator/INDPRO/): Industrial Production: Total Index - [TCU](/indicator/TCU/): Capacity Utilization: Total Index - [PPIACO](/indicator/PPIACO/): Producer Price Index by Commodity: All Commodities - [GDPC1](/indicator/GDPC1/): Real Gross Domestic Product - [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity - [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate - [CES0500000003](/indicator/CES0500000003/): Average Hourly Earnings of All Employees, Total Private - [PAYEMS](/indicator/PAYEMS/): All Employees, Total Nonfarm Macro-to-micro threads including this sector: [Inflation (CPI / PCE / PPI)](/thread/inflation-cpi-pce-ppi/), [US labor market](/thread/us-labor-market/), [Growth & output](/thread/growth-output/), [Money & trade](/thread/money-trade/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/), [Industrial orders & inventories](/thread/industrial-orders/), [Trade & external](/thread/trade-external/). All macro indicators: /indicators/ ## For LLMs & downloads Markdown twin: /company/ARQ.md · JSON record: /company/ARQ.json · verified financials: /company/ARQ/financials.json / /company/ARQ/financials.csv · machine TOC for the whole site: /llms.txt